Literature DB >> 26464720

Association between interluekin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population.

Jianglin Cong1, Riming Liu2, Xuan Wang3, Li Sheng2, Haiyang Jiang3, Weihua Wang2, Youzhong Zhang4, Shujuan Yang5, Chaoying Li5.   

Abstract

We conducted a study to analyze the association of three common SNPs of IL-17A rs2275913 and rs3748067 and IL-17F rs763780 gene polymorphisms with the risk of cervical cancer in a Chinese population. Our study included 352 cervical cancer patients and 352 controls between January 2013 and December 2014. Genotyping of IL-17A rs2275913 and rs3748067 and IL-17F rs763780 genes was performed by multiplex PCR assays using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). By χ(2) test, there was significantly difference in the genotype distribution of IL-17A rs2275913 between cervical cancer patients and control subjects (χ(2)=11.45, P=0.003). By conditional logistic regression analysis, we found that individuals with the GA and AA genotypes were associated with an increased risk of cervical cancer when compared with the GG genotype in codominant model, and the adjusted Ors (95% CI) were 1.57 (1.13-2.18) and 2.01 (1.15-3.49), respectively. In dominant model, we found that the GA+AA genotype of rs2275913 was correlated with a moderate increased risk of cervical cancer compared with the GG genotype (OR=1.64, 95% CI=1.20-2.24). We only found significant interaction between rs2275913 polymorphism and HPV-16 or 18 infection in the risk of cervical cancer (P for interaction <0.05). In conclusion, our study suggests that IL-17A rs2275913 polymorphism may affect the development of cervical cancer in codominant and dominant models, and this gene polymorphism has interaction with HPV-16 or 18 infection.

Entities:  

Keywords:  Interluekin-17; cervical cancer; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26464720      PMCID: PMC4583952     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.

Authors:  Gisela Barbisan; Luis Orlando Pérez; Anahí Contreras; Carlos Daniel Golijow
Journal:  Tumour Biol       Date:  2012-05-17

Review 2.  Interleukin-17 as an effector molecule of innate and acquired immunity against infections.

Authors:  Goro Matsuzaki; Masayuki Umemura
Journal:  Microbiol Immunol       Date:  2007       Impact factor: 1.955

3.  Systemic inflammation as a confounding factor in cancer biomarker discovery and validation.

Authors:  Magdalena Chechlinska; Magdalena Kowalewska; Radoslawa Nowak
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 4.  Functional specialization of interleukin-17 family members.

Authors:  Yoichiro Iwakura; Harumichi Ishigame; Shinobu Saijo; Susumu Nakae
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

Review 5.  Role of cytokines in genesis, progression and prognosis of cervical cancer.

Authors:  Prajakta Hemant Paradkar; Jayashree Vinay Joshi; Priyanka Nirmalsingh Mertia; Shubhada Vidyadhar Agashe; Rama Ashok Vaidya
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.

Authors:  Qinghua Feng; Huafeng Wei; Janice Morihara; Joshua Stern; Mujun Yu; Nancy Kiviat; Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  Gynecol Oncol       Date:  2012-07-22       Impact factor: 5.482

Review 7.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

Review 8.  IL-17 cytokine family.

Authors:  Mio Kawaguchi; Mitsuru Adachi; Naruhito Oda; Fumio Kokubu; Shau-Ku Huang
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

9.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

Authors:  Harumichi Ishigame; Shigeru Kakuta; Takeshi Nagai; Motohiko Kadoki; Aya Nambu; Yutaka Komiyama; Noriyuki Fujikado; Yuko Tanahashi; Aoi Akitsu; Hayato Kotaki; Katsuko Sudo; Susumu Nakae; Chihiro Sasakawa; Yoichiro Iwakura
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

10.  Association between IL17 polymorphisms and risk of cervical cancer in Chinese women.

Authors:  Yi Quan; Bin Zhou; Yanyun Wang; Ruiqi Duan; Kana Wang; Qianqian Gao; Shaoqing Shi; Yaping Song; Lin Zhang; Mingrong Xi
Journal:  Clin Dev Immunol       Date:  2012-09-25
View more
  4 in total

1.  Association Between the Interleukin-17 Gene Polymorphism -197G>A and the Risk of Prostate Cancer in a Galician Population.

Authors:  N Aguín; A Rodríguez-Alonso; N López-Trigo; I P Castuera; J R Luis; B Caeiro
Journal:  Pathol Oncol Res       Date:  2018-11-16       Impact factor: 3.201

Review 2.  Th17 response in patients with cervical cancer.

Authors:  Jayra Juliana Paiva Alves; Thales Allyrio Araújo De Medeiros Fernandes; Josélio Maria Galvão De Araújo; Ricardo Ney Oliveira Cobucci; Daniel Carlos Ferreira Lanza; Fabiana Lima Bezerra; Vânia Sousa Andrade; José Veríssimo Fernandes
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

3.  Variable roles of interleukin-17F in different cancers.

Authors:  Tiina Mikkola; Rabeia Almahmoudi; Tuula Salo; Ahmed Al-Samadi
Journal:  BMC Cancer       Date:  2022-01-11       Impact factor: 4.430

Review 4.  Interleukin-17-A multifaceted cytokine in viral infections.

Authors:  Utkarsha Sahu; Debasis Biswas; Vijay Kumar Prajapati; Anirudh K Singh; Mukesh Samant; Prashant Khare
Journal:  J Cell Physiol       Date:  2021-06-16       Impact factor: 6.513

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.